These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7139671)

  • 21. [HBsAg positive blood donors].
    Holomán J; Glasa J; Stancek D; Páleníková O; Kupcová V; Brixová E
    Vnitr Lek; 1985 Jan; 31(1):39-46. PubMed ID: 3969789
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening tests for HBsAg in transfusion centres of developing countries.
    BMJ; 1988 Sep; 297(6651):792-3. PubMed ID: 3142553
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The contribution of the transfusion network to an understanding of the hepatitis B virus carrier state among the adult population].
    Popovici C; Olaru E
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1989 Apr; 37(4):73-6. PubMed ID: 2512734
    [No Abstract]   [Full Text] [Related]  

  • 27. [On transmission of hepatitis by blood transfusion (author's transl)].
    Fiser-Herman M; Mihaljević I
    Lijec Vjesn; 1981; 103(2-3):108-9. PubMed ID: 7311694
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience in preventing posttransfusion hepatitis in the blood transfusion department of an obstetrics hospital].
    Akulova KG; Mikhaĭlova NI; Shurova LT
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):56-7. PubMed ID: 6445062
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Viral hepatitis morbidity in blood recipients].
    Grinshteĭn EA; Aleĭnik MD; Klimova NIa; Makarevich IK; Karavashkina EV
    Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):16-9. PubMed ID: 7279883
    [No Abstract]   [Full Text] [Related]  

  • 31. HBV--status in professional blood donors in north India.
    Irshad M; Singh YN; Acharya SK
    Trop Gastroenterol; 1992; 13(3):112-4. PubMed ID: 1488797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBsAg amongst unscreened operated patients.
    Ahmad Q; Chowdhury SG; Islam MN; Khan FD; Alam MR; Miah AH
    Bangladesh Med Res Counc Bull; 1991 Jun; 17(1):11-6. PubMed ID: 1953592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Etiological study on chronic and post-transfusion hepatitis].
    Cao HL
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):19-21, 62. PubMed ID: 6525899
    [No Abstract]   [Full Text] [Related]  

  • 34. [Presence of Australia antigen in blood donors].
    Gota F
    Arch Sci Med (Torino); 1980; 137(2):217-20. PubMed ID: 7224843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Remarks on the problem of Australia antigen as an etiologic factor in the outbreak of viral hepatitis].
    Drews J; Sachs V; Waldvogel B
    Dtsch Med Wochenschr; 1971 Nov; 96(48):1893-4. PubMed ID: 5119935
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzyme-linked immunoassay for hepatitis B surface antigen. An evaluation of commercial test kits.
    Nath N; Dodd RY; Fang CT
    Transfusion; 1983; 23(1):45-8. PubMed ID: 6829058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.
    Viet L; Husebekk A; Husum H; Skjerve E
    Transfus Med; 2013 Dec; 23(6):423-31. PubMed ID: 23786316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 39. Australia antigen and post transfusion hepatitis.
    Berthold H; Kleine N; Büttner G; Müller G
    Prog Immunobiol Stand; 1971; 5():63-6. PubMed ID: 4633979
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of using UV-irradiated blood in the prevention of serum hepatitis after blood transfusions during surgery].
    Marchenko AV; Dutkevich IG; Golovin GV; Vykhodtseva VA
    Vestn Khir Im I I Grek; 1990 Feb; 144(2):87-9. PubMed ID: 2165696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.